Influence of chrysin on hepatic marker enzymes and lipid profile against d-galactosamine-induced hepatotoxicity rats

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1654-1659

  Pushpavalli, Ganesan ^a   Veeramani, Chinnadurai ^a   Pugalendi, Kodukkur Viswanathan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Chrysin; D Galactosamine; Hepatic marker enzymes; Kidney function markers; Lipid profile

Indexed keywords

CHRYSIN; GALACTOSAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SILYMARIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG STRUCTURE; FATTY ACID BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HYPERLIPIDEMIA; LIVER PROTECTION; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ANIMALS; DRUG-INDUCED LIVER INJURY; FLAVONOIDS; GALACTOSAMINE; LIVER; MALE; RATS; RATS, WISTAR;

RATTUS; RATTUS NORVEGICUS;

EID: 77952881694     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.040     Document Type: Article

References (48)

1. Allain E.C., Poon L.S., Chan C.S., Richmond W., Fu F.C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974, 20:470-475.
2. Barter P.J., Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis 1996, 21:1-12.
3. Brinton E.A., Eisenberg S., Breslow J.L. A low fat diet decreases high-density lipoprotein (HDL) cholesterol level by decreasing HDL apolipoprotein transport rates. J. Clin. Invest. 1990, 85:144-151.
4. Burtis C.A., Ashwood E.R. Enzymes, Tietz Fundamental of Clinical Chemistry 1996, N.B. Saunders Company, Philadelphia, USA, pp. 4312-4335.
5. Caraway W.T. Determination of uric acid in serum by carbonate method. Am. J. Clin. Pathol. 1995, 25:840-845.
6. Cartwright C.K., Ragland J.B., Weideman S.W., Sabesin S.M. Alterations in lipoprotein composition associated with galactosamine-induced rat liver injury. J. Lipid Res. 1982, 3:667-679.
7. Cho H., Yun C.W., Park W.K., Kong J.Y., Kim K.S., Parky Lees Kim B.K. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNos, by chrysin, derivatives. Pharmacol. Res. 2004, 49:37-43.
8. Critchfield J.W., Butera S.T., Folks T.M. Inhibition of HIV activation in latently infected cells by flavanoid compounds. AIDS Res. Hum. Retroviruses 1996, 12:39-46.
9. Decker K., Keppler D. Galactosamine induced liver injury. Progress in Liver Disease 1972, 183-199. Grune and Stratton, New York. H. Popper, F. Schaffner (Eds.).
10. El-Mofty S.K., Scrutton M.C., Serroni A., Nicolini C., Farber J.L. Fairly reversible plasma membrane injury in galactosamine-induced liver cell death. Am. J. Pathol. 1975, 79:579-596.
11. Falholt K., Falholt W., Lund B. An easy colorimetric method for routine determination of free fatty acids in plasma. Clin. Chim. Acta 1973, 46:105-111.
12. Fawcett J.K., Scott J.E. A rapid and precise method for the determination of urea. J. Clin. Path. 1960, 3:156-159.
13. Fraschini F., Demartini G., Esposti D. Pharmacology of silymarin. Clin. Drug Invest. 2002, 22:51-65.
14. Friedman R.B., Anderson R.E., Entine S.M., Hirshberg S.B. Effects of diseases on clinical laboratory tests. Clin. Chem. 1980, 26:1-476.
15. Friedwald W.T., Levy R.J., Fredricken D.S. Estimation of HDL-C in the plasma without the use of preparative ultracentrifuge. Clin. Chem. 1972, 18:449.
16. Harris Gabriel K., Qian Yong, Leonard Stephen S., Sbarra Deborah C., Shi Xianglin Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. Am. Soc. Nutr. J. Nutr. 2006, 136:1517-1521.
17. Habtemariam S. Flavonoids as inhibitors of enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-926 tumor cells. J. Nat. Prod. 1997, 60:775-778.
18. Izzo C., Grillo F., Murador E. Improved method for the determination of high density lipoprotein cholesterol. Clin. Chem. 1981, 27:371-374.
19. Jaffe M. Concerning the precipitate produced in normal urine by picric acid and a new reaction of creatinine. Physiol. Chem. 1886, 10:91-400.
20. Keppler D., Decker K. Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur. J. Biochem. 1969, 10:219-225.
21. Keppler D., Lesch R., Reutter W., Decker K. Experimental hepatitis induced by d-galactosamine. Exp. Mol. Pathol. 1968, 9:279-290.
22. Keppler D.O., Rudigier J.F., Bischoff E., Decker K.F. The trapping of uridine phosphates by d-galactosamine, d-glucosamine and 2-deoxy-d-galactose. A study on the mechanism of galactosamine hepatitis. Eur. J. Biochem. 1970, 17:246-253.
23. Kind P.N., King E.J. Estimation of plasma phosphatases by determination of hydrolyzed phenol with amino-antipyrine. J. Clin. Pathol. 1954, 7:322-330.
24. Kitamura A., Iso H., Naito Y. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994, 89:25-33.
25. Lapidot T., Walker M.D., Kanner J. Antioxidant and prooxidant effects of phenolics on pancreatic cells in vitro. J. Agricul. Food Chem. 2002, 50:720-725.
26. Lukacinova A., Mojzis J., Benacka R., Keller J., Maguth T., Kurila P., Vasko L., Racz O., Nistiar F. Preventive effect of flavonoids on alloxan-induced diabetes mellitus in rats. Acta Vet. Brno. 2008, 77:175-182.
27. Lim H.K., Kim H.S., Choi H.S., Oh S., Jang C.G., Choi J., Kim S.H., Chang M.J. Effects of acetylbergenin against d-galactosamine-induced hepatotoxicity in rats. Pharmacol. Res. 2000, 42:471-474.
28. Machala M., Kubinova R., Suchy V. Chemoprotective potentials of homoisoflavonoids and chalcones of Dracaena cinnabari: modulations of drug-metabolizing enzymes and antioxidant activity. Phytother. Res. 2001, 15:114-118.
29. Maezona K., Mawatari K., Kajiwara K., Shinkai A., Maki T. Effect of alanine on d-galactosamine induced acute liver failure in rats. Hepatology 1996, 24:1211-1216.
30. Malloy H.T., Evelyn K.A. The determination of bilirubin with the photoelectric colorimeter. J. Biol. Chem. 1937, 119:481-490.
31. Martin P., Fridman L.S. Assessment of live function and diagnostic studies. Hand Book of Liver disease 1992, 1-14. Churchill Livingstone, Philadelphia. L.S. Friedman, E.B. Keefe (Eds.).
32. McGowan M.W., Artiss J.D., Strandbergh D.R., Zak B. A peroxidase coupled method for the colorimetric determination of serum triglycerides. Clin. Chem. 1983, 29:538-542.
33. Myoeliwiec Z., Czerny B., Juÿwiak S., Juzyszyn Z., Musia H.D. Effect of chrysin on selected indices of hepatic function in sodium fluoride subchronic poisoning of rats. Bromat. Chem. Toksykol. 2001, 34:155-158.
34. Perone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights in to old concepts. Clin. Chem. 1992, 38:1933-1953.
35. Reinhold J.G. Manual determination of serum total protein, albumin and globulin fractions by Biuret method. Standard Methods in Clinical Chemistry 1953, 88. Academic Press, New York. M. Reiner (Ed.).
36. Reitman S., Frankel S. A colorimetric method for the determination of serum glutamate oxaloacetic and glutamate pyruvic transminases. Am. J. Clin. Pathol. 1957, 28:56-63.
37. Rosalki S.B., Rau D. Serum gamma-glutamyl transpeptidase activity in alcoholism. Clin. Chem. Acta 1972, 39:41-47.
38. Ross J.A., Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr. 2002, 22:19-34.
39. Sabesin S.M., Kuiken L.B., Ragland J.B. Lipoprotein and lecithin:cholesterol acyltransferase changes in galactosamine induced rat liver injury. Science 1975, 190:1302-1304.
40. Sathish V., Kumar Ebenezar K., Devaki T. Effect of l-arginine and l-lysine on lysosomal enzymes and membrane bound phosphatases in isoproterenol induced myocardial infarction in rats. Mol. Cell. Biochem. 2003, 247:163-169.
41. Taniguchi H., Yomota E., Nogi K., Onoda Y. Effects of anti-ulcer agents on ethanol-induced gastric mucosal lesion in d-GalN-induced hepatitis rats. Drug Res. 2004, 52:600-604.
42. Tietz N.W. Fundamentals of Clinical Chemistry 1987, WB Saunders Company, Philadelphia, p. 638.
43. Tsai C.C., Kao S.T., Hsu C.T., Lin C.C., Lai J.S., Lin J.G. Ameliorative effect of traditional Chinese medicine prescriptions on alpha naphthylisothiocynate and carbon-tetrachloride induced toxicity in rats. Am. J. Chin. Med. 1997, 25:185-196.
44. Villar I.C., Jimenoz R., Galisteo M., Garcio-Saura M.F., Zarzuelo A., Luarte J. Effect of chronic chrysin treatment in spontaneously hypertensive rats. Planta Med. 2002, 68:845-847.
45. Willams C.A., Harborne J.B., Newan M., Greenham J., Eagles J. Chrysin and other leaf exudates flavonoids in the genus Pelargonium. Phytochemistry 1997, 46:1349-1353.
46. Wolfman C., Violah Paladini A., Dajas F., Medina J.H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. 1994, 47:1-4.
47. Yokoyama T., Banta S., Berthiaume F., Nagrath D., Tompkins R.G., Yarmush M.L. Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a d-galactosamine induced rat liver failure model. Metab. Eng. 2005, 7:88-103.
48. Zilversmit D.B., Davis A.K. Micro-determination of plasma phospholipids by trichloroacetic acid precipitation. J. Lab. Clin. Med. 1950, 35:155-159.